New Edge Advisors, LLC Novo Nordisk A S Transaction History

New Edge Advisors, LLC

  • $15 Billion
  • Q3 2024

A detailed history of New Edge Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, New Edge Advisors, LLC holds 322,155 shares of NVO stock, worth $28.1 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
322,155
Previous 318,580 1.12%
Holding current value
$28.1 Million
Previous $45.5 Million 15.65%
% of portfolio
0.26%
Previous 0.34%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.07 - $145.42 $425,675 - $519,876
3,575 Added 1.12%
322,155 $38.4 Million
Q2 2024

Aug 15, 2024
BUY
$122.71 - $146.91 $28.1 Million - $33.6 Million
228,889 Added 255.2%
318,580 $45.5 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $1.78 Million - $2.36 Million
17,390 Added 24.05%
89,691 $11.5 Million
Q4 2023

Feb 13, 2024
BUY
$87.78 - $105.45 $1.84 Million - $2.21 Million
21,003 Added 40.94%
72,301 $7.48 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $2.7 Million - $5.93 Million
29,695 Added 137.46%
51,298 $4.67 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $1.49 Million - $1.65 Million
9,550 Added 79.23%
21,603 $3.5 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $215,978 - $259,716
-1,632 Reduced 11.93%
12,053 $1.92 Million
Q4 2022

Feb 14, 2023
BUY
$102.55 - $135.33 $164,285 - $216,798
1,602 Added 13.26%
13,685 $1.85 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $74,223 - $91,088
-779 Reduced 6.06%
12,083 $1.2 Million
Q2 2022

Aug 09, 2022
SELL
$103.24 - $121.81 $997,298 - $1.18 Million
-9,660 Reduced 42.89%
12,862 $1.43 Million
Q1 2022

May 13, 2022
SELL
$93.1 - $112.54 $62,842 - $75,964
-675 Reduced 2.91%
22,522 $2.5 Million
Q4 2021

Feb 17, 2022
BUY
$95.88 - $117.08 $966,182 - $1.18 Million
10,077 Added 76.81%
23,197 $2.6 Million
Q3 2021

Oct 29, 2021
SELL
$84.42 - $106.62 $99,784 - $126,024
-1,182 Reduced 8.26%
13,120 $1.26 Million
Q2 2021

Jul 22, 2021
BUY
$67.66 - $84.76 $94,791 - $118,748
1,401 Added 10.86%
14,302 $1.2 Million
Q1 2021

Apr 26, 2021
BUY
$67.06 - $75.82 $646,860 - $731,359
9,646 Added 296.34%
12,901 $870,000
Q3 2020

Nov 03, 2020
SELL
$63.69 - $70.22 $6,878 - $7,583
-108 Reduced 3.21%
3,255 $226,000
Q2 2020

Jul 29, 2020
BUY
$58.54 - $67.94 $196,870 - $228,482
3,363 New
3,363 $220,000
Q3 2017

Nov 13, 2017
SELL
$41.15 - $49.22 $3,333 - $3,986
-81 Closed
0 $0
Q2 2017

Aug 16, 2017
BUY
N/A
81
81 $0

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email